What Precision for Medicine does

Precision for Medicine, operating since 2002 and headquartered in Frederick, Maryland, is a global contract research organization (CRO) specializing in biomarker-driven clinical development for complex therapeutic areas, principally oncology (70% of trials) together with rare disease, autoimmune, and advanced cell and gene therapies. The company runs an integrated platform that pairs clinical trial management (regulatory affairs, patient recruitment, monitoring, biostatistics, medical writing, data management) with specialty laboratory and translational services including multi-omics, immune monitoring, flow cytometry, tissue and liquid biopsy analysis, genomics, bioanalysis, and cytokine/proteomics. Core proprietary technologies include the Epiontis ID epigenetic immune-cell phenotyping platform (which works on dried blood spots, simplifying logistics), the ApoStream circulating tumor cell capture platform, and the Precision Site Network of clinical sites purpose-built for precision medicine research, supported by biospecimen collection, matched tissue/blood samples, and clinical logistics across 5 specialty labs in the US and Europe.

The business model is professional services and fee-for-service project billing to pharmaceutical and biotechnology sponsors, delivered through direct enterprise sales, Functional Service Provider (FSP) engagements, and Decentralized Clinical Trial models. Customer segments are explicitly segmented into pharmaceutical/biotech companies, rare disease developers, advanced (cell/gene) therapy developers, and autoimmune disease developers, with therapeutic depth emphasized via dedicated biomarker and translational teams. Operations span 50+ countries with a 500+ employee APAC presence headquartered in Singapore and a new Tokyo office addressing local regulatory data requirements; the firm has conducted over 2,500 cumulative clinical trial and lab projects, including 237 rare oncology trials across 60 countries. The company is privately held under Precision Medicine Group, LLC, has raised disclosed institutional capital of approximately $225M (J.H. Whitney/Oak in 2013 and TPG in 2015), and has executed three disclosed acquisitions since 2016 (Applied Immunology, ProMedDx, Algorics), most recently adding biostatistics and data management scale in 2024.

Name

Precision for Medicine

Legal name

Precision Medicine Group, LLC

Website

https://precisionformedicine.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Precision for Medicine is a global, biomarker-driven contract research organization running integrated clinical trial management and specialty laboratory services for pharmaceutical and biotech sponsors across oncology, rare disease, autoimmune, and cell and gene therapy in 50+ countries.

Ownership category

akta.pro rank

Product category

Clinical Research Organization (CRO) and Specialty Laboratory Services

NAICS

Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE), Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD)

Keywords

• Clinical research services
• Biomarker-driven CRO
• Specialty laboratory services
• Oncology clinical trials
• Cell and gene therapy development

Headquarters

HQ city

Frederick

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. CRO Services: Clinical research organization services including clinical trial management, regulatory affairs, patient recruitment, monitoring, biostatistics, and medical writing. Revenue is generated through project-based service fees charged to pharma and biotech sponsors.
2. Laboratory Services: Specialty lab services including translational sciences, immune monitoring, flow cytometry, tissue biopsy analysis, liquid biopsy, genomics, bioanalysis, cytokine analysis and proteomics. Revenue generated through fee-for-service laboratory testing and assay development.
3. Biospecimens: Provision of human biospecimens including viable cells, tissues, blood products, and matched samples for research and clinical trial use.
4. Regulatory Consulting: Regulatory affairs consulting services including IVD and companion diagnostics regulatory affairs, CDx development, and eCTD submissions.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Precision for Medicine is a global Contract Research Organization (CRO) that provides biomarker-driven clinical research services and integrated specialty laboratory capabilities to pharmaceutical and biotechnology sponsors. Its core offerings encompass clinical trial management and regulatory affairs (Global CRO Services), specialty lab services across multi-omics, immune monitoring, flow cytometry, tissue and liquid biopsy, genomics, bioanalysis, and proteomics (Global Laboratory Services), biospecimen provision, IVD and companion diagnostics development, data management, biostatistics, and commercialization support. The company is therapeutically specialized in oncology, rare disease, autoimmune, and cell and gene therapy programs, operating across more than 50 countries.

Product overview

Precision for Medicine is a global CRO offering an integrated platform of clinical research and laboratory services. The core offerings include Global CRO Services (clinical trial management, regulatory affairs, patient recruitment) and Global Laboratory Services (translational sciences, multi-omics, biomarker analysis). These are supported by specialized modules: Biospecimens (specimen collection and management), Diagnostics & CDx (companion diagnostics development), Data Intelligence (data management and biostatistics), and Commercialization services. The company provides therapeutic expertise in oncology, rare diseases, autoimmune, cell therapy, and gene therapy, with global capabilities across the Americas, Europe, and Asia-Pacific through a network of 5 specialty labs in the US and Europe.

Differentiator

Problem solved

Functional benefit

Brands

• Precision AQ: Investor Relations and External Communications services
• Precision Site Network (PSN)
• Precision FSP Services

Products and services

• Global CRO Services Award-winning CRO services with deep oncology and rare disease expertise, offering clinical trial management, regulatory affairs, patient recruitment, and data management across global operations for pharmaceutical and biotech sponsors.
• Global Laboratory Services Translational and biomarker sciences laboratory services including multi-omics, immune monitoring, flow cytometry, tissue biopsy analysis, liquid biopsy, genomics, bioanalysis, and cytokine analysis with global clinical logistics capabilities for clinical research sponsors.
• Biospecimens Comprehensive biospecimen collection and management including custom collections, matched tissue and blood samples, viable cells (PBMCs, BMMCs, DTCs), tissues (FFPE, fresh frozen), blood and biofluids, and remnant diagnostic specimens for research and clinical trial use.
• Diagnostics & CDx IVD regulatory consulting and companion diagnostics development services for co-development strategies with therapeutics, including CDx regulatory affairs and gene therapy immunogenicity services.
• Data Intelligence Data management and analytics solutions for clinical trial data including clinical data management, centralized monitoring, statistical programming, biostatistics, and data monitoring committee support.
• Commercialization Commercialization support services to help bring innovative therapies to market and empower patient access.
• Multi-Omics & AI Services Multi-omics analysis services integrating genomics, proteomics, and other omics approaches with AI capabilities for biomarker discovery and translational research.
• Immune Monitoring Services Comprehensive immune monitoring including Epiontis ID epigenetic cell phenotyping, ELISpot and Fluorospot assays, cytokine profiling, and custom immune monitoring assays.
• Flow Cytometry Services Flow cytometry services including spectral flow cytometry, receptor occupancy flow assays, cell sorting, and flow cytometry applications in cell therapy development.
• Tissue Biopsy Analysis Tissue analysis services including immunohistochemistry, multiplex immunofluorescence, pathology services, gene expression profiling, and FISH/ISH analysis.
• Liquid Biopsy Analysis Services Liquid biopsy analysis services featuring the ApoStream CTC capture platform for circulating tumor cell isolation and characterization.
• Genomics Services Genomics platform services including ddPCR, qPCR, NGS services, single-cell sequencing, Nanostring assays, and MassARRAY assays for biomarker and genetic analysis.
• Bioanalysis Services Bioanalytical testing services including immunogenicity testing, NAb/TAb assays, PK services, and ELISA for drug development support.
• Cytokine and Protein Biomarker Assays Cytokine and protein biomarker analysis using MSD, Luminex, and Olink Proteomics platforms for biomarker discovery and validation.
• Precision Site Network (PSN) Network of specialized clinical sites for conducting complex clinical trials with experienced investigators and infrastructure optimized for precision medicine research.
• Functional Service Provider (FSP) Flexible Functional Service Provider model providing dedicated functional support across clinical development with scalable resources for sponsor companies.
• Decentralized Clinical Trials Decentralized Clinical Trial services enabling remote patient participation through telemedicine, home health, and real-time monitoring solutions.
• Regulatory Consulting Services Comprehensive regulatory affairs support including IVD & CDx regulatory consulting, companion diagnostics development, gene therapy CDx services, regulatory affairs, and eCTD submission services.
• Clinical Development Strategy Strategic clinical development planning including clinical trial design, biomarker strategies, and basket & umbrella trial design for precision medicine approaches.
• Cell & Gene Therapy Strategies Specialized development strategies for cell and gene therapy programs including regulatory pathway development and clinical trial support.
• Clinical Logistics Services Clinical sample kitting, PBMC processing, global specimen logistics, biospecimen data management, and Precision Lab e-portal services for clinical sample management.

Quantifiable outcome

• Rescued a high-risk hematology-oncology trial through full operational and data gap analysis, rebuilt sponsor alignment, centralized patient-level data monitoring, and custom tracking systems
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Scale indicators10 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Medpace: Mid-sized, therapeutically-focused CRO serving biotech and mid-sized pharma with oncology and rare disease expertise. Closely comparable specialty CRO model targeting the same customer base with full-service clinical development.
• Worldwide Clinical Trials: Mid-sized global CRO with strong scientific expertise in complex indications including oncology, rare disease, and CNS. Directly comparable right-sized alternative to Big Five CROs with similar biotech sponsor focus.
• Novotech: APAC-headquartered full-service CRO with deep oncology concentration and significant early-phase capabilities. Closely comparable specialty CRO model with similar biotech/biopharma customer base, particularly relevant given Precision's APAC expansion.

Broad incumbents

• ICON plc: One of the world's largest CROs offering global clinical development across all therapeutic areas. Operates broadly in the same space as Precision with overlapping oncology/lab services capabilities but at much larger scale and broader portfolio.
• IQVIA: World's largest CRO with extensive biotech services, advanced analytics, and lab capabilities. Broad incumbent operating in same market with overlapping precision medicine and oncology offerings but at substantially greater scale.
• Parexel International: Large global CRO with significant biotech/pharma services and therapeutic expertise in oncology and rare disease. Operates broadly in the same clinical development services space as Precision from a Big Five position.
• Fortrea: Clinical development services spinoff from Labcorp, offering full-service CRO and clinical lab capabilities directly comparable to Precision's integrated CRO-plus-lab model at greater scale.
• Laboratory Corporation of America (Labcorp): Major clinical laboratory services provider with prior CRO arm (now Fortrea). Operates a parallel clinical laboratory and diagnostics business comparable to Precision's laboratory services business with substantially greater scale.
• Syneos Health: Large global CRO with biotech-focused services and clinical development capabilities. Recently went private, similar to Precision, and serves overlapping biotech customer base with broader service portfolio.

Emerging players

• Veristat: Boutique clinical and biostatistics CRO with oncology and rare disease focus. Emerging specialty player with partial overlap in therapeutic expertise and biotech customer focus, smaller scale than Precision.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/precision-for-medicine
• Xx.com/Precision4Med
• Facebookfacebook.com/PrecisionforMedicine

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Precision for Medicine